세계의 하시모토 갑상선염 치료제 시장 : 약제 유형별, 특징별, 최종사용자별, 지역별

The global Hashimoto's thyroiditis drug market was valued at US$ 2.18 Bn in 2023 and is expected to reach US$ 3.40 Bn by 2031, growing at a compound annual growth rate (CAGR) of 5.7% from 2024 to 2031.

Figure 1. Global Hashimoto's Thyroiditis Drug Market Share (%), by Region, 2023

Hashimoto's thyroiditis, also known as chronic lymphocytic thyroiditis, is a long-term autoimmune disease in which the thyroid gland is attacked by the body's immune system. Some of the major symptoms include goiter formation in the neck, fatigue, unexplained weight gain, and sensitivity to cold. It is one of the most common causes of hypothyroidism in the U.S., which it affecting about 14 million Americans and costs billions in treatment annually. A variety of drugs are being used for its management, such as levothyroxine, to replace thyroid hormones, corticosteroids to suppress the immune response, and other symptom management drugs. With increasing incidence rates and overall healthcare cost burden, the Hashimoto's thyroiditis drug market is poised to grow significantly in the coming years.

Market Dynamics:

The Hashimoto's thyroiditis drug market is driven by the rising prevalence of autoimmune diseases globally, growing geriatric population, increasing awareness about the condition, and its management. According to an article published in the National Center for Biotechnology Information (NCBI) in 2023, after age six, Hashimoto is the most common cause of hypothyroidism in the U.S. and in those areas of the world where iodine intake is adequate. Globally, the incidence is estimated to be 0.8 per 1,000 per year in men and 3.5 per 1,000 per year in women. However, lack of awareness in developing nations, high costs of biologic drugs, and social stigma continue to restrain the market growth. On the other hand, the development of targeted therapies, combination drug treatments and online disease communities have opened up opportunities for players in this space. The market is witnessing the rising adoption of oral medications over surgical interventions. Players are investing in R&D to develop novel formulations with improved efficacy and safety profiles.

Key Features of the Study:

• This report provides an in-depth analysis of the global Hashimoto's thyroiditis drug market, and provides market size (US$ Bn) and Compound Annual Growth Rate (CAGR%) for the forecast period (2024-2031), considering 2023 as the base year
• It elucidates potential revenue growth opportunities across different segments and explains attractive investment proposition matrices for this market
• This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players
• It profiles key players in the global Hashimoto's thyroiditis drug market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
• The key companies covered as a part of this study include AbbVie Inc., Merck & Co., Allergan., Amneal Pharmaceuticals., Lannett Company, Mylan Pharmaceuticals, Pfizer, Akorn Pharmaceuticals, Acella Pharmaceuticals, Jerome Stevens Pharmaceuticals, and other prominent players
• Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
• The global Hashimoto's thyroiditis drug market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
• Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global Hashimoto's thyroiditis drug market

Detailed Segmentation:

• By Drug Type
  • Thyroid hormone replacement therapy
  • Anti-inflammatory drugs
  • Antithyroid medications
  • Anti-cretin medications
  • Beta-blockers
  • Calcium channel blockers
  • Others (Supplements and Others)
• By Route of Administration
  • Oral
  • Injections
  • Topical
• By Dosage Form
  • Tablets
  • Capsules
  • Softgels
  • Creams
  • Others (Ointments and Others)
• By End Users
  • Hospitals
  • Sleep Centers
  • Home Care Settings
  • Diagnostic Laboratories
• By Region
  • North America
  • Latin America
  • Europe
  • Asia Pacific
  • Middle East
  • Africa
• Top Companies in the Global Hashimoto's Thyroiditis Drug Market
  • AbbVie Inc.
  • Merck & Co.
  • Allergan
  • Amneal Pharmaceuticals.
  • Lannett Company
  • Mylan Pharmaceuticals
  • Pfizer
  • Akorn Pharmaceuticals
  • Acella Pharmaceuticals
  • Jerome Stevens Pharmaceuticals
  • Other Prominent Players

Table of Contents

1. Research Objectives and Assumptions

• Research Objectives
• Assumptions
• Abbreviations

2. Market Purview

• Report Description
  • Market Definition and Scope
• Executive Summary
  • Global Hashimoto's Thyroiditis Drug Market, By Drug Type
  • Global Hashimoto's Thyroiditis Drug Market, By Route of Administration
  • Global Hashimoto's Thyroiditis Drug Market, By Dosage Form
  • Global Hashimoto's Thyroiditis Drug Market, By Distribution Channel
  • Global Hashimoto's Thyroiditis Drug Market, By Region
• Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

• Market Dynamics
  • Drivers
  • Restraints
  • Opportunities
• Impact Analysis
• Key Highlights
• Regulatory Scenario
• Product Launches/Approvals
• PEST Analysis
• PORTER's Analysis
• Merger and Acquisition Scenario

4. Global Hashimoto's Thyroiditis Drug Market - Impact of Coronavirus (COVID-19) Pandemic

• COVID-19 Epidemiology
• Supply Side and Demand Side Analysis
• Economic Impact

5. Global Hashimoto's Thyroiditis Drug Market, By Drug Type, 2019-2031, (US$ Bn)

• Introduction
  • Market Share Analysis, 2024 and 2031 (%)
  • Y-o-Y Growth Analysis, 2020 - 2031
  • Segment Trends
• Thyroid hormone replacement therapy
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2019-2031,(US$ Bn)
• Anti-inflammatory drugs
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2019-2031,(US$ Bn)
• Antithyroid medications
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2019-2031,(US$ Bn)
• Anti-cretin medications
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2019-2031,(US$ Bn)
• Beta-blockers
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2019-2031,(US$ Bn)
• Calcium channel blockers
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2019-2031,(US$ Bn)
• Others (Supplements and Others)
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2019-2031,(US$ Bn)

6. Global Hashimoto's Thyroiditis Drug Market, By Route of Administration, 2019-2031, (US$ Bn)

• Introduction
  • Market Share Analysis, 2024 and 2031 (%)
  • Y-o-Y Growth Analysis, 2020 - 2031
  • Segment Trends
• Oral
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2019-2031,(US$ Bn)
• Parenteral
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2019-2031,(US$ Bn)
• Topical
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2019-2031,(US$ Bn)

7. Global Hashimoto's Thyroiditis Drug Market, By Dosage Form, 2019-2031, (US$ Bn)

• Introduction
  • Market Share Analysis, 2024 and 2031 (%)
  • Y-o-Y Growth Analysis, 2020 - 2031
  • Segment Trends
• Tablets
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2019-2031,(US$ Bn)
• Capsules
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2019-2031,(US$ Bn)
• Softgels
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2019-2031,(US$ Bn)
• Creams
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2019-2031,(US$ Bn)
• Others (Ointments and Others)
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2019-2031,(US$ Bn)

8. Global Hashimoto's Thyroiditis Drug Market, By Distribution Channel, 2019-2031, (US$ Bn)

• Introduction
  • Market Share Analysis, 2024 and 2031 (%)
  • Y-o-Y Growth Analysis, 2020 - 2031
  • Segment Trends
• Hospital Pharmacies
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2019-2031,(US$ Bn)
• Retail Pharmacies
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2019-2031,(US$ Bn)
• Online Pharmacies
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2019-2031,(US$ Bn)

9. Global Hashimoto's Thyroiditis Drug Market, By Region, 2019-2031, (US$ Bn)

• Introduction
  • Market Share Analysis, By Region, 2024 and 2031 (%)
  • Y-o-Y Growth Analysis, For Region, 2020 - 2031
  • Country Trends
• North America
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Drug Type, 2019-2031,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2019-2031,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Dosage Form, 2019-2031,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2019-2031,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2019-2031,(US$ Bn)
• U.S.
• Canada
• Latin America
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Drug Type, 2019-2031,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2019-2031,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Dosage Form, 2019-2031,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2019-2031,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2019-2031,(US$ Bn)
• Brazil
• Argentina
• Mexico
• Rest of Latin America
• Europe
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Drug Type, 2019-2031,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2019-2031,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Dosage Form, 2019-2031,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2019-2031,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2019-2031,(US$ Bn)
• Germany
• U.K.
• Spain
• France
• Italy
• Russia
• Rest of Europe
• Asia Pacific
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Drug Type, 2019-2031,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2019-2031,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Dosage Form, 2019-2031,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2019-2031,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2019-2031,(US$ Bn)
• China
• India
• Japan
• Australia
• South Korea
• ASEAN
• Rest of Asia Pacific
• Middle East
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Drug Type, 2019-2031,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2019-2031,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Dosage Form, 2019-2031,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2019-2031,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2019-2031,(US$ Bn)
• GCC
• Israel
• Rest of Middle East
• Africa
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Drug Type, 2019-2031,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2019-2031,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Dosage Form, 2019-2031,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2019-2031,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2019-2031,(US$ Bn)
• South Africa
• North Africa
• Central Africa

10. Competitive Landscape

• AbbVie Inc.
• Merck & Co.
• Amneal Pharmaceuticals.
• Lannett Company
• Mylan Pharmaceuticals
• Pfizer
• Akorn Pharmaceuticals
• Acella Pharmaceuticals
• Jerome Stevens Pharmaceuticals
• Other Prominent Players
• Analyst Views

11. Section

• Research Methodology
• About us